- T cell therapy trains the immune system to find cancer.
- These treatments help some people but not all patients.
- The therapy depends on a T cell receptor protein.
- Scientists used a special microscope to view the receptor.
- They put the receptor into a small membrane patch.
- The resting receptor stayed closed and folded inside the membrane.
- When it met a target molecule, it opened like a spring.
- Assembling the membrane and proteins was hard for researchers.
- The new view could help improve future immunotherapies.
Difficult words
- receptor — a protein that receives signals on cells
- membrane — a thin layer that surrounds a cell
- microscope — a tool that makes very small things bigger
- assemble — to put parts together to make somethingAssembling
- immune — the body's system that fights germs and disease
- target — a thing or molecule that is the aim
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever seen a microscope?
- Would you like to work in medical research?
- Do you think new cancer treatments are important?
Related articles
Virtual diet and exercise program helps people with lymphoma
A study tested a virtual diet and exercise program for people getting chemotherapy for lymphoma. The program improved symptoms, attendance was high, and participants had better strength and physical performance during treatment.
New modular CAR-T system controls where and when cells attack
Researchers at the University of Chicago created GA1CAR, a modular CAR-T system that uses short-lived Fab fragments to guide and pause tumor targeting. In animal tests the same cells were redirected to different tumors and remained functional.
Biosensor reveals cancer-specific vulnerability in PRMT5
Researchers found that a metabolite change in some tumors makes the protein PRMT5 bind MTA instead of SAM. A new NanoBRET biosensor and a probe called CBH-002 measure drug binding to this cancer-specific form of PRMT5 in live cells.